pamidronate has been researched along with Calcinosis in 26 studies
Calcinosis: Pathologic deposition of calcium salts in tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae." | 5.56 | Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. ( Dash, M; Giri, S; Panda, M; Parida, JR, 2020) |
| "A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen." | 5.40 | Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. ( Martillotti, J; Moote, D; Zemel, L, 2014) |
| "A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided." | 5.36 | Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. ( Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S, 2010) |
| "Treatment with pamidronate resulted in only a slight enhancement of mineralization." | 2.84 | Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation. ( Blouin, S; Fratzl-Zelman, N; Glorieux, FH; Klaushofer, K; Marini, JC; Rauch, F; Roschger, P, 2017) |
| "Ectopic calcinosis rarely occurs in systemic lupus erythematosus (SLE) patients." | 2.39 | Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus. ( Ishikawa, H; Ito, O; Kasukawa, R; Kurokawa, M; Miyata, M; Nishimaki, T; Sekine, H; Watanabe, S, 1996) |
| "Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae." | 1.56 | Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. ( Dash, M; Giri, S; Panda, M; Parida, JR, 2020) |
| "Pamidronate (PAM) has been widely used for this purpose because of its high binding affinity toward bone and remarkable therapeutic effects." | 1.42 | Charge and hydrophobicity effects of NIR fluorophores on bone-specific imaging. ( Bao, K; Choi, HS; Gibbs, SL; Gravier, J; Hyun, H; Lee, JH; Nasr, KA, 2015) |
| "A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen." | 1.40 | Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. ( Martillotti, J; Moote, D; Zemel, L, 2014) |
| "A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided." | 1.36 | Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. ( Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S, 2010) |
| " In the present study, we demonstrated the effects of vitamin K(2) alone or in combination with pamidronate in an arterial calcification model induced using inorganic phosphate in cultured bovine aortic smooth muscle cells (BASMCs)." | 1.34 | Treatment with vitamin k(2) combined with bisphosphonates synergistically inhibits calcification in cultured smooth muscle cells. ( Saito, E; Sato, F; Seyama, Y; Sugitani, H; Wachi, H, 2007) |
| "Cytostatic treatment of multiple myeloma in combination with repetitive i." | 1.29 | Reversible metastatic pulmonary calcification in a patient with multiple myeloma. ( Frickhofen, N; Friedrich, JM; Hoffmeister, A; Mattfeldt, T; Merkle, E; Prümmer, O; Weber, CK, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (15.38) | 18.7374 |
| 1990's | 9 (34.62) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Giri, S | 1 |
| Parida, JR | 1 |
| Dash, M | 1 |
| Panda, M | 1 |
| Blouin, S | 1 |
| Fratzl-Zelman, N | 1 |
| Glorieux, FH | 1 |
| Roschger, P | 1 |
| Klaushofer, K | 1 |
| Marini, JC | 1 |
| Rauch, F | 1 |
| Martillotti, J | 1 |
| Moote, D | 1 |
| Zemel, L | 1 |
| Palaniappan, P | 1 |
| Lionel, AP | 1 |
| Kumar, S | 1 |
| Bao, K | 1 |
| Nasr, KA | 1 |
| Hyun, H | 1 |
| Lee, JH | 1 |
| Gravier, J | 1 |
| Gibbs, SL | 1 |
| Choi, HS | 1 |
| Lomashvili, KA | 1 |
| Monier-Faugere, MC | 1 |
| Wang, X | 1 |
| Malluche, HH | 1 |
| O'Neill, WC | 1 |
| Neven, EG | 1 |
| De Broe, ME | 1 |
| D'Haese, PC | 1 |
| Slimani, S | 1 |
| Abdessemed, A | 1 |
| Haddouche, A | 1 |
| Ladjouze-Rezig, A | 1 |
| Bayou, F | 1 |
| Belajouza, C | 1 |
| Boussofara, L | 1 |
| Ghariani, N | 1 |
| Denguezli, M | 1 |
| Bouajina, E | 1 |
| Nouira, R | 1 |
| Christidou, F | 1 |
| Bamichas, G | 1 |
| Stangou, M | 1 |
| Natse, T | 1 |
| Kalpakidis, V | 1 |
| Sombolos, K | 1 |
| Mayahara, M | 1 |
| Sasaki, T | 1 |
| Saito, E | 1 |
| Wachi, H | 1 |
| Sato, F | 1 |
| Sugitani, H | 1 |
| Seyama, Y | 1 |
| Nimni, ME | 2 |
| Hirsch, D | 1 |
| Schoen, FJ | 4 |
| Levy, RJ | 4 |
| Weber, CK | 1 |
| Friedrich, JM | 1 |
| Merkle, E | 1 |
| Prümmer, O | 1 |
| Hoffmeister, A | 1 |
| Mattfeldt, T | 1 |
| Frickhofen, N | 1 |
| Van Gelder, JM | 1 |
| Breuer, E | 2 |
| Schlossman, A | 1 |
| Ornoy, A | 2 |
| Mönkkönen, J | 1 |
| Similä, J | 1 |
| Klenner, T | 1 |
| Stadler, H | 1 |
| Krempien, B | 1 |
| Patlas, N | 2 |
| Golomb, G | 3 |
| Miyata, M | 1 |
| Kurokawa, M | 1 |
| Watanabe, S | 1 |
| Ishikawa, H | 1 |
| Sekine, H | 1 |
| Ito, O | 1 |
| Nishimaki, T | 1 |
| Kasukawa, R | 1 |
| Patashnik, S | 1 |
| Rabinovich, L | 1 |
| Cohen, H | 1 |
| Solomon, V | 1 |
| Alferiev, IS | 1 |
| Eidelman, N | 1 |
| Hägele, G | 1 |
| Phanish, MK | 1 |
| Kallarackal, G | 1 |
| Ravanan, R | 1 |
| Lawson, TM | 1 |
| Baboolal, K | 1 |
| Webb, CL | 3 |
| Nguyen, NM | 1 |
| Ertl, D | 1 |
| Villanueva, J | 1 |
| Nimni, BS | 1 |
| Jones, M | 1 |
| Eidbo, EE | 1 |
| Hilbert, SL | 1 |
| Ferrans, VJ | 1 |
| Clark, RE | 1 |
| Benedict, JJ | 1 |
| Linden, JA | 1 |
| Fleisch, H | 1 |
2 reviews available for pamidronate and Calcinosis
| Article | Year |
|---|---|
Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus.
Topics: Adult; Calcinosis; Diphosphonates; Female; Finger Joint; Humans; Hydroxycholecalciferols; Lupus Eryt | 1996 |
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperpar | 1985 |
1 trial available for pamidronate and Calcinosis
| Article | Year |
|---|---|
Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.
Topics: Adolescent; Bone Density; Calcinosis; Cancellous Bone; Child; Child, Preschool; Collagen Type I; Col | 2017 |
23 other studies available for pamidronate and Calcinosis
| Article | Year |
|---|---|
Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis.
Topics: Calcinosis; Child; Child, Preschool; Dermatomyositis; Female; Fingers; Humans; Male; Pamidronate | 2020 |
Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
Topics: Bone Density Conservation Agents; Calcinosis; Child; Dermatomyositis; Diphosphonates; Female; Humans | 2014 |
Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate.
Topics: Calcinosis; Child; Dermatomyositis; Diphosphonates; Dose-Response Relationship, Drug; Drug Administr | 2014 |
Charge and hydrophobicity effects of NIR fluorophores on bone-specific imaging.
Topics: Animals; Bone and Bones; Calcinosis; Diphosphonates; Female; Fluorescent Dyes; Hydrophobic and Hydro | 2015 |
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
Topics: Animals; Aortic Diseases; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcinosis; D | 2009 |
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
Topics: Animals; Aortic Diseases; Calcification, Physiologic; Calcinosis; Diphosphonates; Etidronic Acid; Hu | 2009 |
Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.
Topics: Adolescent; Bone Density Conservation Agents; Calcinosis; Calcium; Cholecalciferol; Dermatomyositis; | 2010 |
[Aggressive universal calcinosis complicating dermatomyositis].
Topics: Adolescent; Anti-Bacterial Agents; Calcinosis; Combined Modality Therapy; Cutaneous Fistula; Dermato | 2011 |
Tumoral calcinosis inducing systemic inflammatory response in a hemodialysis patient.
Topics: Aged; Calcinosis; Diphosphonates; Hip Joint; Hip Prosthesis; Humans; Inflammation; Male; Pamidronate | 2002 |
Cellular mechanism of inhibition of osteoclastic resorption of bone and calcified cartilage by long-term pamidronate administration in ovariectomized mature rats.
Topics: Acid Phosphatase; Animals; Apoptosis; Bone Resorption; Calcinosis; Cartilage; Diphosphonates; Dose-R | 2003 |
Treatment with vitamin k(2) combined with bisphosphonates synergistically inhibits calcification in cultured smooth muscle cells.
Topics: Calcinosis; Cells, Cultured; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Humans; Musc | 2007 |
Biochemistry of bone induction and dystrophic calcification.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone Demineralization Technique; Bone Diseases, Met | 1994 |
Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity.
Topics: Alkaline Phosphatase; Animals; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Etidronic Acid; Gl | 1993 |
Reversible metastatic pulmonary calcification in a patient with multiple myeloma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Calcinosis; Diphosphonates; Fema | 1996 |
In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.
Topics: Animals; Bioprosthesis; Bone Resorption; Calcinosis; Carcinoma 256, Walker; Cell Line; Cell Survival | 1997 |
Preparation and evaluation of chitosan microspheres containing bisphosphonates.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Resorption; Calcinosis; Cattle; Chitin; Chito | 1997 |
Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Betaine; Bone and Bones; Bone Resorption; Calcinosis | 1998 |
Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate.
Topics: Adult; Anti-Inflammatory Agents; Arthritis; C-Reactive Protein; Calcinosis; Diphosphonates; Fever; H | 2000 |
Calcification of allograft aortic wall in a rat subdermal model. Pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Aorta; Aortic Diseases; Calcinosis; Chlori | 1992 |
Inhibition of ectopic calcification of glutaraldehyde crosslinked collagen and collagenous tissues by a covalently bound diphosphonate (APD).
Topics: Animals; Biocompatible Materials; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Heart Valve Pro | 1990 |
Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: stability and calcification inhibition studies.
Topics: Aldehydes; Animals; Bioprosthesis; Calcinosis; Diphosphonates; Disease Models, Animal; Glutaral; Hea | 1989 |
Anticalcification treatments of bioprosthetic heart valves: in vivo studies in sheep.
Topics: Acrylic Resins; Animals; Biocompatible Materials; Bioprosthesis; Calcinosis; Diphosphonates; Heart V | 1989 |
Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
Topics: Aldehydes; Animals; Aortic Valve Stenosis; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Diseas | 1988 |